NIKE, Inc. (NKE) Stock Analysis
Is NKE a good investment?
NIKE, Inc. (NKE) has a Plutrex AI rating of 37.0/100 as of August 22, 2026, indicating a Sell consensus. The stock is halal-compliant per AAOIFI standards. Key strength: Cash position of $9.03B provides exceptional liquidity runway — supports dividends, buybacks, and turnaround execution without distress risk or forced asset sales. Main concern: PEG ratio of 4.38 is 213% above the industry average of 1.40 — Nike is the most expensive stock on a growth-adjusted basis in its peer group, paying 4.38x a 5-year EPS CAGR of only 4.21% vs. peers compounding at 16.73%; this is the single most critical overvaluation signal.
Investment Summary
Nike (NKE) at $40.76 remains a Sell. The investment case is undermined by three compounding problems: (1) Structural overvaluation — PEG ratio of 4.38 is 213% above the industry average of 1.40, meaning investors pay 4.38x Nike's long-term growth rate of 4.21% vs. peers growing EPS at 16.73% annually; (2) Competitive deterioration — revenue contracting -1.1% while the industry expands +8.85%, net margin of 6.70% is 44% below the peer average of 12.02%, and gross margin of 43.1% trails the industry's 53.2%; (3) Deeply negative news sentiment (17.9/100, 13 of 16 articles negative) with the stock hitting a 12-year low below $40 and fresh 52-week lows at $39.42. The analyst consensus target of $49.71 implies 21.9% upside, but this is a sentiment-driven recovery estimate, not a fundamentally justified intrinsic value. At current prices, the risk/reward is unfavorable. The stock is NOT a buy at $40.76. Wait for the $33.00–$36.50 entry zone where the margin of safety becomes compelling.
Key Strengths
- Cash position of $9.03B provides exceptional liquidity runway — supports dividends, buybacks, and turnaround execution without distress risk or forced asset sales
- Next-year EPS growth of 25.97% is 38% above the industry average of 18.82%, confirming the earnings trough is likely behind the company and a near-term recovery catalyst is real
- Analyst consensus target of $49.71 implies 21.9% upside from $40.76, and Nike's global brand moat, 170+ country distribution, and athlete endorsement ecosystem provide qualitative competitive advantages not captured in current depressed financials
Key Concerns
- PEG ratio of 4.38 is 213% above the industry average of 1.40 — Nike is the most expensive stock on a growth-adjusted basis in its peer group, paying 4.38x a 5-year EPS CAGR of only 4.21% vs. peers compounding at 16.73%; this is the single most critical overvaluation signal
- Revenue contracting -1.1% while the industry grows +8.85% (a 9.95pp gap), combined with net margin of 6.70% that is 44% below the industry average of 12.02%, stock hitting 12-year lows with sentiment score of 17.9/100 (13 of 16 articles negative), and China weakness continuing to pressure results — structural competitive deterioration is ongoing with no measurable turnaround evidence yet
Plutrex 10-Factor AI Breakdown
Fundamental Analysis
Nike's fundamentals confirm a premium brand in structural decline. Profitability: Gross margin 43.1% (vs. industry 53.2% — 10pp deficit), operating margin 12.7% (vs. industry 17.0% — 4.3pp deficit), net margin 6.7% (vs. industry 12.0% — 5.3pp deficit, the largest gap). ROE of 22.1% is below the industry average of 26.6%, partially supported by leverage (D/E 0.58). Growth: Revenue growth -1.1% vs. industry +8.85% — Nike is losing top-line ground. 5-year forward EPS CAGR of 4.21% vs. industry 16.73% — the most critical long-term metric and the most damning. Next-year EPS growth of 26% is real but represents a low-base recovery (prior-year EPS fell -51%), not structural acceleration. Valuation: P/E of 19.16 appears moderate but paired with 4.21% long-term growth yields a PEG of 4.38 — deeply overvalued on a growth-adjusted basis. A fair P/E for 4.21% growth at PEG=1.0 implies ~$9 per share; even at PEG=2.0 (generous premium), fair value is ~$27. Graham formula (EPS × (8.5 + 2×4.21)) yields ~$37. Health: Cash of $9.03B is strong; FCF of $1.89B implies ~3% FCF yield at current market cap — insufficient. D/E of 0.58 is manageable. Overall: Great brand, deteriorating financials, unjustified premium valuation.
News Sentiment
Nike's stock is in freefall — and Wall Street is asking whether the bottom is finally near. The world's most iconic sportswear brand has seen its shares plunge to a 12-year low, briefly dropping below $40 per share and touching a fresh 52-week low of $39.42, according to recent reports. That's a staggering collapse from the $96 peak in 2021, wiping out roughly $200 billion in market value. The headline 'Nike stock lost $200B in value since its 2021 highs: what is ailing the sports giant?' captures the scale of the destruction. The culprit? A perfect storm of problems. China — once Nike's growth engine — is now its biggest headache, with weakness in the region overshadowing any progress in wholesale channels, as one headline noted: 'Nike Falls 3% to a Fresh 52-Week Low as China Weakness Overshadows Its Wholesale...' Meanwhile, the turnaround story that management has been promising remains unproven. Articles like 'As the Nike stock implodes, is it safe to buy the dip or sell the rip?' reflect the genuine uncertainty investors face. There are faint glimmers of hope — 'Nike Just Hit a 12-Year Low. Is the Bottom Near?' and '1 Number That Makes Nike's Turnaround Worth Watching This Month' suggest some analysts see a potential inflection point, particularly around the cash infusion and near-term earnings recovery. But with 13 of 16 recent articles negative and a sentiment score of just 17.9 out of 100, the market's verdict is clear: Nike's turnaround has yet to earn investor trust.
Risk Assessment
PRIMARY RISK: Valuation remains the dominant risk — at $40.76, the PEG of 4.38 leaves no margin of safety if the 5-year EPS growth of 4.21% proves accurate. A re-rating to PEG=2.0 (still a 43% premium to the industry average of 1.40) implies fair value of ~$27, representing 34% downside from current levels. SECONDARY RISK: China weakness is structural, not cyclical — management faces pressure to accelerate China recovery or diversify revenue, and neither is a quick fix. Revenue contraction of -1.1% while peers grow 8.85% suggests market share loss that may be difficult to reverse. TERTIARY RISK: Technical momentum is deeply negative — stock at 12-year lows ($39.42 52-week low), down from $96 in 2021, with 13 of 16 recent news articles negative. Sentiment score of 17.9/100 suggests further downside pressure is possible before stabilization. MITIGATION: Wait for the $33.00–$36.50 entry zone. At $34.75 midpoint, upside to analyst target of $49.71 is 43%, producing a risk/reward of 2.8x against a stop at $30.50. Position size capped at 2% given ongoing uncertainty. The $9.03B cash position and dividend provide a floor against catastrophic downside.
Related Halal Stocks
Related Stocks
Frequently Asked Questions
Is NKE a halal stock?
Yes, NIKE, Inc. (NKE) is halal-compliant per AAOIFI standards as of the latest quarterly review.
What is Plutrex's AI rating for NKE?
NIKE, Inc. (NKE) has a Plutrex AI rating of 37.0/100 with a Sell consensus, based on a 10-factor analysis covering financial health, growth, valuation, profitability, debt, analyst sentiment, technical momentum, insider confidence, news sentiment, and halal compliance.
Is NKE a good investment?
According to Plutrex AI, NKE has a Sell rating (37.0/100). For the full analysis including trading plan and risk assessment, see the detailed breakdown above.
How can I invest in NKE?
US stocks like NKE can be bought through international brokers such as Interactive Brokers, accessible to Arab investors. Plutrex provides comprehensive analysis plus AI-generated trading plans with entry points, stop losses, and profit targets.
What are the main risks of investing in NKE?
Plutrex AI identifies the main risks for NKE by analyzing valuation, debt, market sentiment, and macro factors. See the Risk Assessment section above for the full breakdown.